Cancer Rx Reimbursement Made Smoother By Survival Benefit, Genentech Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Survival data also helps oncologics avoid possible safety issues, CFO Ebersman said. Furthermore, if a product shows a survival benefit it creates an effective defensive strategy by establishing itself as standard of care.